Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000499482) titled 'Silicosis Treatment with Infliximab - A Key Evaluation (STRIKE)' on May 22.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Alfred Health
Condition:
Silicosis
Silicosis
Respiratory - Other respiratory disorders / diseases
Intervention:
The STRIKE trial is a single-centre, investigator-initiated pilot study assessing the efficacy of infliximab in patients with artificial stone-associated complicated silicosis. Safety and feasibility will also be assessed...